Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Vitamin B3 Market by Product Type (Pharmaceutical Grade, Feed Grade), by Applications (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals) and by Distribution Channel (Hypermarkets Supermarkets, Food Specialty Stores, Pharmacy, Cosmetic Discounters, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A15457

Pages: NA

Charts: NA

Tables: NA

Niacin (vitamin b3), also known as nicotinic acid, is an organic molecule that is usually classified as one of the 20 to 80 necessary nutrients for humans. It is part of the vitamin B3 complex, which is made up of nicotinamide and other vitamins. It's made up of C6H5NO2 and belongs to the pyridine carboxylic acids family.

Many processed meals with a greater concentration of fortified packaged goods, tuna, salmon, and certain vegetables include niacin (vitamin b3). People who have high blood cholesterol and a niacin or vitamin B3 deficiency often take niacin supplements.The vitamin is essential for the body, and a lack of it can result in nausea, skin and mouth sores, anemia, migraines, and exhaustion. A lack of five essential vitamins, niacin, vitamin C, thiamin, vitamin D, and vitamin A, causes a niacin deficiency in persons with pandemic deficient illnesses.

COVID-19 Impact Analysis

The influence of COVID-19 on feed consumption has had a direct impact on meat and livestock products and byproducts, such as milk and eggs. Worldwide, there has been an increase in the demand for plant-based vitamin supplements and nutritional alternatives, which have strengthened the market for such supplements.Several vitamin B3 supplements with immunity-boosting qualities, are on the market, and sales have increased since the introduction of the new coronavirus to reduce the risk of infection.

Following the epidemic and the resulting global lockdown, people's health awareness has increased dramatically, resulting in a heightened demand for items that boost immunity. Due to the lockdowns, closures of international borders, and delays in cross-border transit caused by the COVID-19 epidemic throughout regions, manufacturing of vitamin B3 is expected to stall in 2020. Governments around the world are taking steps like social distancing to limit the number of people who can work together in the workplace.From 2021 onwards, the market for vitamin B3 will gradually revive as government limitations are projected to relax.

Despite the fact that food demand is increasing, COVID-19 has had a substantial influence on supply. Lockdowns and a spike in infected cases have resulted in manpower shortages and a decrease in raw material supplies.

Food supplies have been delayed as a result of the disruption in delivery channels. The demand for vitamin B3 processing in the milk and dairy industry, on the other hand, is rising now and is expected to rise further in the first and second quarters of 2021.

Top Impacting Factors

  • During the forecast period, the healthcare industry is expected to fuel the market's overall growth.
  • Because niacin is so important to one's health, the use of niacin supplements is on the rise around the world, which is expected to promote market growth.
  • Vitamin B3 deficiency can result in nausea, skin and mouth sores, anemia, headaches, and exhaustion. Take niacin pills to avoid these folks, which are expected to boost the market expansion even further.
  • Niacin supplementation can assist to lower the risk of heart disease. The demand for niacin is predicted to increase as a result of this cause.
  • During the projection period, people who avoid taking external supplements are expected to limit market growth.
  • People's lack of understanding of niacin (Vitamin B3) is expected to stymie market expansion over the forecast period.

Market Trends

  • Increased Demand for Monogastric Animal Nutrition Supplements
  • Because monogastric animals are unable to generate vitamin B complex molecules in the same way that ruminants do, there is a high demand for vitamin supplements in this industry. Due to the coordinated growth of these sectors, key businesses are building a market presence in the poultry and swine sectors. In developing countries, such as Asia Pacific and Latin America, these industries are gaining traction. Globally, there has been a significant demand for the usage of additives in these expanding markets due to the increase in demand for complex feed in these regions.
  •  
  • Changes in Regulatory Policies as a Result of Environmental Impact

If suitable standard operating procedures are not followed, the production process of vitamin B3, which is mostly synthetic, is thought to have a potentially negative impact on the environment. The vast majority of synthetic vitamins are made from petroleum extracts and coal tar derivatives, both of which have substantial environmental consequences. Vitamin manufacturing is thought to cause a significant amount of pollution, prompting vitamin makers to take initiatives to reduce their carbon footprint.The Chinese government's change in environmental rules is one of the primary challenges affecting the worldwide vitamin market. To achieve sustainable production and prevent air pollution, the Chinese government has implemented rigorous limitations. Vitamin manufacturers in China are experiencing a difficulty in that they must boost production to satisfy rising demand, which has an impact on worldwide vitamin supplies. Concerns over the long-term production of vitamins in other countries may also prompt national governments to take similar steps.

Key Benefits of the Report

  • This study presents the analytical depiction of the vitamin b3 industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the vitamin b3 market share.
  • The current market is quantitatively analyzed to highlight the vitamin b3 market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed vitamin b3 market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Report

  • Which are the leading players active in the ‘vitamin b3 market’?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is “vitamin b3 market” prediction in the future?
  • Which will be the niches at which players profiling with recent advancements should set a presence?
  • What are the driving factors and opportunities in the market?
  • What are the current trends and predicted trends?
  • What are the challenges faced in the "vitamin b3 market"?

Key Market Segments

  • By Product Type
    • Pharmaceutical Grade
    • Feed Grade
  • By Applications
    • Feed Additives
    • Food and Drinks Industry
    • Pharmaceutical Industry
    • Daily Chemicals
  • By Distribution Channel
    • Hypermarkets & Supermarkets
    • Food Specialty Stores
    • Pharmacy
    • Cosmetic Discounters
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa


Key Market Players

  • Zhejiang Guobang Pharmaceutical Co. Ltd.
  • Nutrient Treatment International Co., Ltd.
  • Solvay Pharmaceuticals
  • OEL Pharm Tech
  • BASF SE
  • Tianjin Aikang Biotechnology Co., Ltd.
  • Vitablend Nederland
  • Shijiazhuang Donrex Co., Ltd.
  • Yantai Dongcheng Biochemicals Co., Ltd.
  • Prinova Group
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: VITAMIN B3 MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Pharmaceutical Grade

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Feed Grade

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: VITAMIN B3 MARKET, BY APPLICATIONS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Applications

    • 5.2. Feed Additives

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Food And Drinks Industry

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Pharmaceutical Industry

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Daily Chemicals

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: VITAMIN B3 MARKET, BY DISTRIBUTION CHANNEL

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Distribution Channel

    • 6.2. Hypermarkets And Supermarkets

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Food Specialty Stores

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Pharmacy

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Cosmetic Discounters

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: VITAMIN B3 MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Applications

      • 7.2.4. Market Size and Forecast, By Distribution Channel

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Vitamin B3 Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Applications
        • 7.2.6.3. Market Size and Forecast, By Distribution Channel
      • 7.2.7. Canada Vitamin B3 Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Applications
        • 7.2.7.3. Market Size and Forecast, By Distribution Channel
      • 7.2.8. Mexico Vitamin B3 Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Applications
        • 7.2.8.3. Market Size and Forecast, By Distribution Channel
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Applications

      • 7.3.4. Market Size and Forecast, By Distribution Channel

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Vitamin B3 Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Applications
        • 7.3.6.3. Market Size and Forecast, By Distribution Channel
      • 7.3.7. Germany Vitamin B3 Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Applications
        • 7.3.7.3. Market Size and Forecast, By Distribution Channel
      • 7.3.8. Italy Vitamin B3 Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Applications
        • 7.3.8.3. Market Size and Forecast, By Distribution Channel
      • 7.3.9. Spain Vitamin B3 Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Applications
        • 7.3.9.3. Market Size and Forecast, By Distribution Channel
      • 7.3.10. UK Vitamin B3 Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Applications
        • 7.3.10.3. Market Size and Forecast, By Distribution Channel
      • 7.3.11. Russia Vitamin B3 Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Applications
        • 7.3.11.3. Market Size and Forecast, By Distribution Channel
      • 7.3.12. Rest Of Europe Vitamin B3 Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Applications
        • 7.3.12.3. Market Size and Forecast, By Distribution Channel
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Applications

      • 7.4.4. Market Size and Forecast, By Distribution Channel

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Vitamin B3 Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Applications
        • 7.4.6.3. Market Size and Forecast, By Distribution Channel
      • 7.4.7. Japan Vitamin B3 Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Applications
        • 7.4.7.3. Market Size and Forecast, By Distribution Channel
      • 7.4.8. India Vitamin B3 Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Applications
        • 7.4.8.3. Market Size and Forecast, By Distribution Channel
      • 7.4.9. South Korea Vitamin B3 Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Applications
        • 7.4.9.3. Market Size and Forecast, By Distribution Channel
      • 7.4.10. Australia Vitamin B3 Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Applications
        • 7.4.10.3. Market Size and Forecast, By Distribution Channel
      • 7.4.11. Thailand Vitamin B3 Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Applications
        • 7.4.11.3. Market Size and Forecast, By Distribution Channel
      • 7.4.12. Malaysia Vitamin B3 Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Applications
        • 7.4.12.3. Market Size and Forecast, By Distribution Channel
      • 7.4.13. Indonesia Vitamin B3 Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Applications
        • 7.4.13.3. Market Size and Forecast, By Distribution Channel
      • 7.4.14. Rest of Asia Pacific Vitamin B3 Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Applications
        • 7.4.14.3. Market Size and Forecast, By Distribution Channel
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Applications

      • 7.5.4. Market Size and Forecast, By Distribution Channel

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Vitamin B3 Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Applications
        • 7.5.6.3. Market Size and Forecast, By Distribution Channel
      • 7.5.7. South Africa Vitamin B3 Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Applications
        • 7.5.7.3. Market Size and Forecast, By Distribution Channel
      • 7.5.8. Saudi Arabia Vitamin B3 Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Applications
        • 7.5.8.3. Market Size and Forecast, By Distribution Channel
      • 7.5.9. UAE Vitamin B3 Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Applications
        • 7.5.9.3. Market Size and Forecast, By Distribution Channel
      • 7.5.10. Argentina Vitamin B3 Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Applications
        • 7.5.10.3. Market Size and Forecast, By Distribution Channel
      • 7.5.11. Rest of LAMEA Vitamin B3 Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Applications
        • 7.5.11.3. Market Size and Forecast, By Distribution Channel
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. BASF SE

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Zhejiang Guobang Pharmaceutical Co. Ltd.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Prinova Group

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Vitablend Nederland

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Nutrient Treatment International Co., Ltd.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. OEL Pharm Tech

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Solvay Pharmaceuticals

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Yantai Dongcheng Biochemicals Co., Ltd.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Shijiazhuang Donrex Co., Ltd.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Tianjin Aikang Biotechnology Co., Ltd.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL VITAMIN B3 MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL VITAMIN B3 MARKET FOR PHARMACEUTICAL GRADE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL VITAMIN B3 MARKET FOR FEED GRADE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL VITAMIN B3 MARKET, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL VITAMIN B3 MARKET FOR FEED ADDITIVES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL VITAMIN B3 MARKET FOR FOOD AND DRINKS INDUSTRY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL VITAMIN B3 MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL VITAMIN B3 MARKET FOR DAILY CHEMICALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL VITAMIN B3 MARKET, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL VITAMIN B3 MARKET FOR HYPERMARKETS AND SUPERMARKETS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL VITAMIN B3 MARKET FOR FOOD SPECIALTY STORES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL VITAMIN B3 MARKET FOR PHARMACY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL VITAMIN B3 MARKET FOR COSMETIC DISCOUNTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL VITAMIN B3 MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL VITAMIN B3 MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA VITAMIN B3, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 20. U.S. VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 22. U.S. VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 23. CANADA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 24. CANADA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 25. CANADA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE VITAMIN B3, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 39. ITALY VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 40. ITALY VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 41. ITALY VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 45. UK VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 46. UK VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 47. UK VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC VITAMIN B3, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 58. CHINA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 59. CHINA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 60. CHINA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 64. INDIA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 65. INDIA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 66. INDIA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA VITAMIN B3, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 98. UAE VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 99. UAE VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 100. UAE VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA VITAMIN B3, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA VITAMIN B3, BY APPLICATIONS, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA VITAMIN B3, BY DISTRIBUTION CHANNEL, 2025-2033 ($MILLION)
  • TABLE 107. BASF SE: KEY EXECUTIVES
  • TABLE 108. BASF SE: COMPANY SNAPSHOT
  • TABLE 109. BASF SE: OPERATING SEGMENTS
  • TABLE 110. BASF SE: PRODUCT PORTFOLIO
  • TABLE 111. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 113. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 114. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 115. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 116. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. PRINOVA GROUP: KEY EXECUTIVES
  • TABLE 118. PRINOVA GROUP: COMPANY SNAPSHOT
  • TABLE 119. PRINOVA GROUP: OPERATING SEGMENTS
  • TABLE 120. PRINOVA GROUP: PRODUCT PORTFOLIO
  • TABLE 121. PRINOVA GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. VITABLEND NEDERLAND: KEY EXECUTIVES
  • TABLE 123. VITABLEND NEDERLAND: COMPANY SNAPSHOT
  • TABLE 124. VITABLEND NEDERLAND: OPERATING SEGMENTS
  • TABLE 125. VITABLEND NEDERLAND: PRODUCT PORTFOLIO
  • TABLE 126. VITABLEND NEDERLAND: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: KEY EXECUTIVES
  • TABLE 128. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 129. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: OPERATING SEGMENTS
  • TABLE 130. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 131. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. OEL PHARM TECH: KEY EXECUTIVES
  • TABLE 133. OEL PHARM TECH: COMPANY SNAPSHOT
  • TABLE 134. OEL PHARM TECH: OPERATING SEGMENTS
  • TABLE 135. OEL PHARM TECH: PRODUCT PORTFOLIO
  • TABLE 136. OEL PHARM TECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. SOLVAY PHARMACEUTICALS: KEY EXECUTIVES
  • TABLE 138. SOLVAY PHARMACEUTICALS: COMPANY SNAPSHOT
  • TABLE 139. SOLVAY PHARMACEUTICALS: OPERATING SEGMENTS
  • TABLE 140. SOLVAY PHARMACEUTICALS: PRODUCT PORTFOLIO
  • TABLE 141. SOLVAY PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: KEY EXECUTIVES
  • TABLE 143. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: COMPANY SNAPSHOT
  • TABLE 144. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: OPERATING SEGMENTS
  • TABLE 145. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 146. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. SHIJIAZHUANG DONREX CO., LTD.: KEY EXECUTIVES
  • TABLE 148. SHIJIAZHUANG DONREX CO., LTD.: COMPANY SNAPSHOT
  • TABLE 149. SHIJIAZHUANG DONREX CO., LTD.: OPERATING SEGMENTS
  • TABLE 150. SHIJIAZHUANG DONREX CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 151. SHIJIAZHUANG DONREX CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES
  • TABLE 153. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 154. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: OPERATING SEGMENTS
  • TABLE 155. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 156. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL VITAMIN B3 MARKET SEGMENTATION
  • FIGURE 2. GLOBAL VITAMIN B3 MARKET
  • FIGURE 3. SEGMENTATION VITAMIN B3 MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN VITAMIN B3 MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVITAMIN B3 MARKET
  • FIGURE 11. VITAMIN B3 MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. VITAMIN B3 MARKET FOR PHARMACEUTICAL GRADE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. VITAMIN B3 MARKET FOR FEED GRADE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. VITAMIN B3 MARKET SEGMENTATION, BY BY APPLICATIONS
  • FIGURE 15. VITAMIN B3 MARKET FOR FEED ADDITIVES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. VITAMIN B3 MARKET FOR FOOD AND DRINKS INDUSTRY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. VITAMIN B3 MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. VITAMIN B3 MARKET FOR DAILY CHEMICALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. VITAMIN B3 MARKET SEGMENTATION, BY BY DISTRIBUTION CHANNEL
  • FIGURE 20. VITAMIN B3 MARKET FOR HYPERMARKETS AND SUPERMARKETS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. VITAMIN B3 MARKET FOR FOOD SPECIALTY STORES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. VITAMIN B3 MARKET FOR PHARMACY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. VITAMIN B3 MARKET FOR COSMETIC DISCOUNTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. VITAMIN B3 MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: VITAMIN B3 MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. BASF SE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. BASF SE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. BASF SE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. ZHEJIANG GUOBANG PHARMACEUTICAL CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. PRINOVA GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. PRINOVA GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. PRINOVA GROUP: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. VITABLEND NEDERLAND: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. VITABLEND NEDERLAND: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. VITABLEND NEDERLAND: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. NUTRIENT TREATMENT INTERNATIONAL CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. OEL PHARM TECH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. OEL PHARM TECH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. OEL PHARM TECH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. SOLVAY PHARMACEUTICALS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. SOLVAY PHARMACEUTICALS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. SOLVAY PHARMACEUTICALS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. YANTAI DONGCHENG BIOCHEMICALS CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. SHIJIAZHUANG DONREX CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. SHIJIAZHUANG DONREX CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. SHIJIAZHUANG DONREX CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. TIANJIN AIKANG BIOTECHNOLOGY CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Vitamin B3 Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue